{"nct_id":"NCT00697775","title":"Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents","status":"COMPLETED","status_verified_date":"2008-06","start_date":"1998-03","start_date_type":null,"primary_completion_date":"1999-05","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE2"],"tickers":["GSK"]}